Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future
- PMID: 20831288
- DOI: 10.2165/11535260-000000000-00000
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future
Abstract
Health systems that have fixed budgets and a coherent organizational structure generally have found it valuable to have a dedicated primary research capacity to answer decision-oriented value-for-money questions of particular importance to the system. The UK NHS is one example of such a system. Here, we review the historical evolution of building comparative effectiveness research (CER) capacity in the NHS, describe the current situation, with a focus on how this research is used to inform decisions, and discuss present and emerging challenges. We draw some possible lessons for the US, which is currently considering using CER to inform healthcare policy and practice decisions.
Similar articles
-
The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.Pain Physician. 2011 May-Jun;14(3):E249-82. Pain Physician. 2011. PMID: 21587337 Review.
-
Comparative effectiveness research in practice and policy for radiation oncology.Semin Radiat Oncol. 2014 Jan;24(1):54-60. doi: 10.1016/j.semradonc.2013.09.001. Semin Radiat Oncol. 2014. PMID: 24314343 Review.
-
Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.Pain Physician. 2010 Jan-Feb;13(1):E23-54. Pain Physician. 2010. PMID: 20119474 Review.
-
Investigation of comparative effectiveness research in Asia, Europe, and North America.Indian J Pharmacol. 2015 Nov-Dec;47(6):585-93. doi: 10.4103/0253-7613.169592. Indian J Pharmacol. 2015. PMID: 26729947 Free PMC article. Review.
-
Assessing comparative effectiveness research in the US.Appl Health Econ Health Policy. 2009;7(4):219-24. doi: 10.1007/BF03256155. Appl Health Econ Health Policy. 2009. PMID: 19905035
Cited by
-
What values do the public want their health care systems to use in evaluating technologies?Eur J Health Econ. 2011 Aug;12(4):285-8. doi: 10.1007/s10198-011-0320-4. Eur J Health Econ. 2011. PMID: 21573933 Free PMC article. No abstract available.
-
Translating comparative effectiveness research into clinical practice: the UK experience.Drugs. 2012 Jan 22;72(2):163-70. doi: 10.2165/11630860-000000000-00000. Drugs. 2012. PMID: 22268389
-
Perspectives on comparative effectiveness research: views from diverse constituencies.Pharmacoeconomics. 2010;28(10):789-98. doi: 10.2165/11535790-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831287 No abstract available.
-
Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.Pharmacoeconomics. 2013 Jun;31(6):455-69. doi: 10.1007/s40273-013-0063-4. Pharmacoeconomics. 2013. PMID: 23640103 Free PMC article. Review.
-
A framework for describing health care delivery organizations and systems.Am J Public Health. 2015 Apr;105(4):670-9. doi: 10.2105/AJPH.2014.301926. Epub 2014 Jun 12. Am J Public Health. 2015. PMID: 24922130 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous